| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/10/1995 | US5380761 Transdermal compositions |
| 01/10/1995 | US5380750 Arylethylamine compounds |
| 01/10/1995 | US5380726 Interleukin inhibitors |
| 01/10/1995 | US5380712 Truncated human serum albumin polypeptides as plasma expanding agents |
| 01/10/1995 | US5380711 Methods for delipidation of skin and cerumen removal |
| 01/10/1995 | US5380527 Softeners, moisturizers |
| 01/10/1995 | CA2117399A1 Topically administrable zinc phthalocyanine compositions |
| 01/05/1995 | WO1995000651A1 Recombinant stratum corneum chymotryptic enzyme (scce) |
| 01/05/1995 | WO1995000501A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | WO1995000136A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/05/1995 | WO1995000115A1 Utilization of a peptide having a lysin group and an alanine group in the terminal position for the preparation of a depigmenting composition, and depigmenting composition thus obtained |
| 01/05/1995 | CA2364039A1 Use of phenyl heterocycles in the relief or treatment of rheumatoid arthritis, osteoarthritis, fever, pain, headache or dysmenorrhea |
| 01/05/1995 | CA2164955A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/05/1995 | CA2163888A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | CA2161436A1 Antiproliferative naphthyridines |
| 01/04/1995 | EP0631779A1 Use of esters of L-carnitine and acyl L-carnitine with hydroxyacids for producing pharmaceutical compositions for treating dermatoses |
| 01/04/1995 | EP0470231B1 Composition and use of the composition for the manufacture of a medicament for the treatment of injuries caused by the radiation of heat and light |
| 01/03/1995 | US5378720 Treatment of rheumatoid arthritis, emphysema, pancreatitis |
| 01/03/1995 | US5378472 Modified with levulinic acid |
| 01/03/1995 | US5378453 Composition for promoting melanin formation for hair coloring |
| 01/03/1995 | US5378451 Topical medicinal pressurized aerosol compositions and method of preparation, method of use and article of manufacture thereof |
| 01/03/1995 | CA2127216A1 Cosmetic composition containing a superoxyde dismutase and a melanin pigment in association |
| 12/28/1994 | EP0630650A1 Preparation for skin and mucoses containing nitric acid |
| 12/28/1994 | EP0630252A1 Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections |
| 12/28/1994 | EP0630247A1 Topical compositions containing steroids |
| 12/28/1994 | EP0346429B1 Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2) |
| 12/28/1994 | CN1027136C Wound healing |
| 12/27/1994 | US5376667 Derivatives of benzoylecgonine, ecgonine and their multiple pharmacological properties |
| 12/27/1994 | US5376651 Use of 20(R)-22-oxa-vitamin D analogues for the treatment of skin ageing |
| 12/27/1994 | US5375693 Methods and compositions for treating allergic disorders and other disorders metabolic derivatives of terfenadine |
| 12/23/1994 | CA2125238A1 Use of esters of l-carnitine and acyl l-carnitine with hydroxyacids for producing pharmaceutical compositions for treating dermatoses |
| 12/22/1994 | WO1994029462A1 Multicistronic expression of recombinant genes in bacterial cells |
| 12/22/1994 | WO1994029336A1 New peptide derivatives |
| 12/22/1994 | WO1994029299A1 Imidazole lipoxygenase inhibitors |
| 12/22/1994 | WO1994029262A1 Lipoxin compounds |
| 12/22/1994 | WO1994028907A2 Use of corrinoids in topical treatment of skin diseases |
| 12/22/1994 | WO1994028897A2 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
| 12/22/1994 | WO1994028894A1 Lotion |
| 12/22/1994 | DE4420690A1 Use of chaulmoogra oils in cosmetics and pharmacy, in particular dermatology for equalising the pigmentation of the skin |
| 12/22/1994 | CA2164641A1 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
| 12/21/1994 | EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them |
| 12/21/1994 | EP0629397A1 Cosmetic or pharmaceutical composition for topical application active against free radicals |
| 12/21/1994 | EP0610368A4 Treatment of acne or of pseudofolliculitis barbae. |
| 12/21/1994 | CN1027065C Tetralin esters of phenols or benzoic acids |
| 12/20/1994 | US5374772 Substituted benzoic acids, inhibitors of phospholipases A2 |
| 12/20/1994 | US5374660 Asministering a benzoic hydrazide to treat antigrowth of fibroblasts, fibronectins, collagen |
| 12/20/1994 | US5374629 Vitamin D analogues |
| 12/20/1994 | EP0650366A4 Compositions and methods for treating wounds. |
| 12/20/1994 | CA1333616C 19-nor-vitamin d compounds |
| 12/20/1994 | CA1333570C Topically applicable preparations for treatment of presbyderma |
| 12/18/1994 | CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them |
| 12/14/1994 | EP0628309A1 Use of O-esters of L-carnitine for the treatment of dermatoses |
| 12/14/1994 | EP0628308A1 Use of O-esters of L-carnitine with aromatic acids for the treatment of dermatoses |
| 12/14/1994 | EP0628305A1 Stable oil-in-water emulsion type cosmetic or dermatologic composition containing at least one vegetable oil comprising at least 40% triglycerides derived from linolic acid |
| 12/14/1994 | EP0628040A1 Indole derivatives as steroid 5 alpha-reductase inhibitors |
| 12/14/1994 | EP0627909A1 Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract |
| 12/14/1994 | EP0543864B1 Novel vitamin d analogues |
| 12/14/1994 | CN1096203A Traditional Chinese medicine ointment for curing burns and preparing method |
| 12/13/1994 | US5373012 Useful in treatment of hair growth and cardiovascular disorder |
| 12/08/1994 | WO1994027990A1 INDOLE DERIVATIVES AS STEROID 5α-REDUCTASE INHIBITORS |
| 12/08/1994 | WO1994027988A1 Optically pure salts of pyridinylmethyl sulfinyl-ih-benzimidazole compounds |
| 12/08/1994 | WO1994027633A1 Bandage for continuous application of biologicals |
| 12/08/1994 | WO1994027594A2 Stable copper(i) complexes and methods related thereto |
| 12/08/1994 | WO1994027563A1 Inhibition of hair growth |
| 12/08/1994 | CA2337581A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds and intermediates in the preparation therefor |
| 12/08/1994 | CA2163640A1 Stable copper (i) complexes and their use as active therapeutic substances |
| 12/07/1994 | EP0626969A1 CoA-IT AND PAF INHIBITORS |
| 12/07/1994 | EP0626955A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 12/07/1994 | EP0626954A1 Benzocycloheptenes, benzoxepines and benzothiepines |
| 12/07/1994 | EP0626940A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
| 12/07/1994 | EP0626864A1 Topical composition containing hyaluronic acid and nsaids |
| 12/07/1994 | EP0626844A1 Compositions of clindamycin and benzoyl peroxide for acne treatment |
| 12/07/1994 | EP0612211A4 Alteration of rate and character of hair growth. |
| 12/06/1994 | USRE34805 Benzonaphthalene derivatives and their use in therapeutic and cosmetic compositions |
| 12/06/1994 | US5371206 DNA encoding chimeric fibroblast growth factors |
| 12/03/1994 | CA2124748A1 Use of o-esters of l-carnitine with aromatic acids for producing pharmaceutical compositions for the treatment of dermatoses |
| 11/30/1994 | EP0626389A1 Recombinant antibodies specific for TNF-alpha |
| 11/30/1994 | EP0626378A1 Saccharin derivative proteolytic enzyme inhibitors |
| 11/30/1994 | CN1095720A Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same |
| 11/30/1994 | CN1095714A Phthalazinone derivatives |
| 11/30/1994 | CN1026789C Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
| 11/29/1994 | US5369126 Nonatetraenoic acid derivative for use in treating acne |
| 11/29/1994 | US5369117 5-(3-formylamino-4-hydroxyphenyl)-3-(1-(4-methoxyphenyl)prop-2-yl)-oxazolidines |
| 11/29/1994 | US5368868 Nonionic surfactants of ethylene propylene oxide copolymers |
| 11/29/1994 | CA2124402A1 Use of o-esters of l-carnitine for producing pharmaceutical compositions for the treatment of dermatoses |
| 11/29/1994 | CA1333285C Morpholinoethylester of mycophenolic acid and derivatives thereof |
| 11/26/1994 | CA2122886A1 Saccharin derivative proteolytic enzyme inhibitors |
| 11/24/1994 | WO1994026735A1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
| 11/24/1994 | WO1994026710A1 INDOLE DERIVATIVES AS TESTOSTERONE 5α-REDUCTASE INHIBITORS |
| 11/24/1994 | WO1994026707A1 Vitamin d amide derivatives |
| 11/24/1994 | WO1994026300A1 Insulin-like growth factor ii as antitumour agent |
| 11/24/1994 | WO1994026297A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 11/24/1994 | WO1994026269A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton |
| 11/24/1994 | WO1994026268A1 Methods and compositions using optically pure (+)-zileuton |
| 11/24/1994 | WO1994026249A1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 11/24/1994 | WO1994026240A1 Composition for the treatment of impaired hair growth |
| 11/24/1994 | WO1994022441A3 Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases |
| 11/24/1994 | WO1994016709A3 Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 11/24/1994 | CA2162594A1 Insulin-like growth factor ii as antitumour agent |
| 11/24/1994 | CA2162272A1 Vitamin d amide derivatives |